|
Publications |
|
- Y. Çapan Formulation de Comprimés de Nitrofurantoin à Libération Modifiée Obtenus par Compression Directe Labo-Pharma-Probl. Tech., 31, 837 (1983)
- Y. Çapan Les Formes Pharmaceutiques Orales Solides à Libération Programée. Sci. Techn. Pharm., 13, 43 (1984)
- Y. Çapan Influence of Technological Factors on Formulation of Sustained Release Tablets. Drug Dev. Ind. Pharm., 15, 927 (1989)
- Y. Çapan, S. Şenel, S. Çalış, S. Takka, A. A. Hıncal Formulation and In Vitro- In Vivo Evaluations on Sustained Release Acetylsalicylic Acid Tablets. Pharm. Ind., 51, 443 (1989)
- F. Bulut-Öner, Y. Çapan, S. Kaş, L. Öner, A. A. Hıncal Sustained Release Isoniasid Tablets. I. Formulation and In Vitro Evaluation Farmaco., 44 ,739 (1989)
- K. Çiftçi, Y. Çapan, O. Öztürk, A. A. Hıncal Formulation and In Vitro- In Vivo Evaluation of Sustained Release Lithium Carbonate Tablets. Pharm. Res. , 7, 359 (1990)
- Y. Çapan, S. Kaş, L. Öner, F. Bulut-Öner, A. A. Hıncal Sustained Release Isoniasid Tablets II. In Vivo Evaluation S.T.P. Pharma Sciences, 6, 460 (1990)
-Y. Çapan, K. Çiftçi, A.A. Hıncal Influence of Filler Excipients on the Release Rate of Sustained Release Lithium Carbonate Tablets. Eur. J. Pharm. Biopharm., 37, 14 (1991)
- K. Çiftçi, Y. Çapan, A. A. Hıncal Evaluation of Sustained Release Lithium Carbonate Tablets from Urine S.T.P. Pharma Sciences, 1, 272 (1991)
- S. Şenel, Y. Çapan, T. Dalkara, N. İnanç, A. A. Hıncal Formulation, Bioavailability and Pharmacokinetics of Sustained Release Potassium Chloride Tablets. Pharm. Res., 8, 1313 (1991)
- S. Şenel, Y. Çapan, A. A. Hıncal Factors Affecting the Formulation of Sustained Release Potassium Chloride Tablets Pharmazie, 46, 792 (1991)
- Y. Çapan, N. Çapan, H. S. Kaş, Ş. Atikcan, Y. Başer, A. A. Hıncal Formulation and Efficiency of Sustained Release Theophylline Tablets S.T.P. Pharma Sciences, 2, 169 (1992)
- Ş. Anlar, Y. Çapan, A. A. Hıncal Physico-Chemical and Bioadhesive Properties of Polyacrylic Acid Polymers. Pharmazie, 48, 285 (1993)
- Ş. Anlar, Y. Çapan, O. Güven, A. Göğüş, T. Dalkara, A. A. Hıncal Formulation and In vitro- In vivo Evaluation of Buccoadhesive Morphine Sulphate Tablets. Pharm. Res., 11, 231 (1994)
- F.S. Farshi, Y. Çapan, S. Kas, A.A. Hıncal Formulation and Comparative Bioavailability of Conventional and Sustained- Release Furosemide Tablets. S.T.P. Pharma Sciences, 5, 361 (1995)
- B. Taylan, Y. Çapan, O. Güven, S. Kas, A. A. Hıncal Design and Evaluation of Sustained-Release and Buccoadhesive Propranolol Hydrochloride Tablets. J. Control. Rel., 38, 11 (1996)
-S. Şenel, Y. Çapan, M.F. Sargon, G. İkinci, D. Şolpan , O. Güven, H.E. Bodde, A.A.Hıncal Enhancement of Transbuccal Permeation of Morphine Sulfate by Sodium Glycodeoxycholate In Vitro. J. Control. Rel., 45, 153 (1997)
- S. Şenel, D. Duchêne, A.A. Hıncal, Y. Çapan, G. Ponchel In Vitro Studies on Enhancing Effect of Sodium Glycocholate on Transbuccal Permeation of Morphine Hydrochloride. J. Control. Rel., 51, 107 (1998)
- S. Şenel, Y. Çapan, M.F. Sargon, C.B. Giray, A.A. Hıncal Histological and Bioadhesion Studies on Buccal Bioadhesive Tablets Incorporated with a Penetration Enhancer, Sodium Glycodeoxycholate. Int. J. Pharm., 170, 239 (1998)
- Y. Yazıksız-İşcan, Y, Çapan, S. Şenel, M.F. Şahin, S. Kes, D. Duchêne, A. Atilla Hıncal. Formulation and In vitro In vivo Evaluation of Buccal Bioadhesive Captopril Tablets STP Pharma, 8, 357 (1998)
- G.İkinci, Y.Çapan, S.Şenel, T. Dalkara, A.A. Hıncal Formulation and In Vitro-In Vivo investigation of carbamazepine controlled release matrix tablets Pharmazie, 54, 139 (1999)
-Y.Çapan, B.H. Woo, S. Gebrekidan, S.Ahmed, P.P.DeLuca. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of plasmid DNA. Pharm. Res. 16, 509 (1999)
- Y.Çapan, B.H. Woo, S. Gebrekidan, S.Ahmed, P.P.DeLuca Influence of formulation parameters on the characteristics of poly(D,L- lactide-co- glycolide) microsphere containing poly(L-lysine)complexed plasmid DNA. J. Control. Rel. 60, 279 (1999)
- Y.Çapan, B.H. Woo, S. Gebrekidan, S.Ahmed, P.P.DeLuca Stability of poly(L-Lysine) complexed plasmid DNA. Pharm.Dev. Tech. 4, 491 (1999)
- G. İkinci, Y. Çapan, S. Şenel, E. Alaaddinoğlu, T. Dalkara, A. A. Hıncal In vitro/in vivo studies on buccal bioadhesive tablet formulation of carbamazepine Pharmazie, 55,762 (2000).
- Y. Çapan, G. Jiang, S. Giovagnoli, K. Na, P. P. DeLuca Preparation and characterization of poly(D,L- lactide-co-glycolide) microspheres for controlled release of human growth hormone AAPS PhamSciTech, 4, 236 (2003).
- R. Elqidra, N. Ünlü, Y. Çapan, G. Şahin, T. Dalkara, A. A. Hıncal Effect of polymorphism on in vitro- in vivo properties of carbamazepine conventional tablets. J. Drug Del. Sci. Tech., 14,147,( 2004)
- S. Bozdağ, Y. Çapan, İ.Vural, T. Dalkara, A.L. Dogan, D. Guc, A. A. Hıncal, In vitro Cytotoxıcıty of Mitoxantron-Incorporated Albumin Microspheres on Acute Promyelocytic Leukemia Cells Journal of Microencapsulation, 21,751 (2004)
- S. Bozdağ, Y. Çapan, İ.Vural, T. Dalkara, A.L. Dogan, D. Guc, A. A. Hıncal, P.P.DeLuca, Formulation and In Vitro Cytotoxicity of Mitoxantron- Loaded Biodegradable Microspheres on Rat Glioma Cells J. Drug Del. Sci. Tech., 15, 201 ( 2005 )
- Y.Aktas, K.Andrieux, M.J.Alonso, P.Calvo, R.N.Gursoy, P.Couvreur, Y.Capan Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor Int J Pharm. 298,378 (2005)
- A.C. Kilic, Y. Capan, I. Vural, R. N. Gursoy, T. Dalkara, A. Cuine, A. Hincal, Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-spesific antisense oligonucleotides to the NMDA receptors in the brain Journal of Microencapsulation 22,633 (2005)
- M. Cetin, Y.Capan, İ.Vural, L.A.Dogan, D.Guc, A.A.Hincal, P.Wehrlé, T.Dalkara, P.P.DeLuca, Preparation and Characterization of bFGF and BSA Loaded Microspheres, J.Drug Del. Sci. Tech.15,371 (2005)
- D. H.Na, J. Faraj, Y.Capan, K.P. Leung, P.P. DeLuca Chewing gum of antimicrobial decapeptide (KSL) as a sustained antiplaque J Control Release 107 ,122 (2005)
- Aktas Y, Yemisci M, Andrieux K, Gursoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Quinoa E, Riguera R, Sargon MF, Celik HH, Demir AS, Hincal AA, Dalkara T, Capan Y, Couvreur P. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug. Chem. 16,1503(2005)
- M.Yemisci, İ.Vural, S. Bozdağ, M. Çetin, F. Söylemezoğlu, Y. Çapan, T. Dalkara,Treatment of Malignant Glioma with Mitoxantrone-Loaded PLGA Microspheres,Neurosurgery. 59 ,1296 (2006)
- JA. Faraj , R. Dorati , A. Schoubben, D. Worthen, F. Selmin,Y. Capan, K. Leung, P The Development of a Peptide Containing Chewing Gum as a Sustained ReleaseAntiplaque Antimicrobial Delivery System. AAPSPharmSci.Tech. 8 (1), 26 (2007)
- Na DH, Faraj J, Capan Y, Leung KP, DeLuca PP. Stability of antimicrobial decapeptide (KSL) and its analogues for delivery in the
- Cetin, M., Aktas, Y., Vural, I., Capan, Y.; Preparation and In Vitro Evaluation of bFGF-Loaded Chitosan Nanoparticles; Drug Delivery; 14, 1–5; (2007)
- Cetin M, Youn YS, Capan Y, Lee KC. Preparation and Characterization of Salmon Calcitonin-biotin Conjugates. AAPS PharmSciTech. 9(4), 1191-7; (2008)
R., Riguera, R., Couvreur, P., Capan, Y. Preparation and Evaluation of PBN-Encapsulated Chitosan and PEGylated Chitosan Nanoparticles Pharmazie, 64(7):436-9; (2009)
- A. Aktaş, B. Giray, Y. Çapan, D. Menemenlioğlu, M. Hayran, G. İkinci, İ. Vural, Microbiological and clinical comparison of chlorhexidine buccoadhesive tablet and chlorhexidine mouthrinse, J. Drug Del. Sci. Tech., 19 (5) 353-357 2009
- Karatas H, Aktas Y, Gursoy-Ozdemir Y, Bodur E, Yemisci M, Caban S, Vural A, Pinarbasili O, Capan Y, Fernandez-Megia E, Novoa-Carballal R, Riguera R, Andrieux K, Couvreur P, Dalkara T, A nano-medicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection, J. Neuroscience 2009 Nov 4;29(44):13761-9
|
|
Journal Articles (Refereed) |
|
Journal Articles (Not Refereed) |
|
- N. Ünlü, Y. Çapan, N. Yuluğ Formulation Studies of the Wetting Solutions for Hard Contact Lenses I. Microbiyol. Bull., 15, 179 (1981)
- N. Ünlü, Y. Çapan, N. Yuluğ Formulation Studies of the Wetting Solutions for Hard Contact Lenses II. FABAD J. Pharm. Sci., 7, 125 (1982)
-Y. Çapan Le Choix des Excipients en Compression Directe à l'Aide des Energies de Compression FABAD J. Pharm. Sci. , 9, 108 (1984)
- T. Eldem, Y. Çapan Formulation Studies on Sustained Release Nitrofurantoin Tablets. Bull. Hacettepe University Faculty of Pharmacy 4, 9 (1984)
- Y. Çapan, A. A. Hıncal The Physics of Tablet Compression I. FABAD J. Pharm. Sci. 9, 93 (1984)
- Y. Çapan, A. A. Hıncal The Physics of Tablet Compression II. The Strength of Tablets. FABAD J. Pharm. Sci., 11, 82 (1986)
- S.Şenel, Y.Çapan, A.A.Hıncal Applications of Thermal Analysis in Pharmaceutics. FABAD J. Pharm. Sci., 17, 45 (1992)
- Ş. Anlar, Y. Çapan, A. A. Hıncal Bioadhesive Controlled Release Systems I Fundamentals of Bioadhesion. FABAD J. Pharm. Sci., 17, 203 (1992)
- Ş. Anlar, Y. Çapan, A. A. Hıncal Bioadhesive Controlled Release Systems II. Experimental Methods for Evaluation of Bioadhesive Bond Strength of Polymers with Mucus. FABAD J. Pharm. Sci., 17, 277 (1992)
- Y. Çapan Properties and Evaluation of Sustained Release Tablets. FABAD J. Pharm. Sci., 18, 27( 1993)
- F.S. Farshi, Y. Çapan, A.A. Hıncal Topographical Dissolution Characterization for Sustained-Release Furosemide Tablets. Acta Pharmaceutica Turcica., 36, 118 (1994)
- Y.Çapan ISO 9000 Standards and GMP POSYON, 3, 12 (1994)
- Y. Çapan Quality Assurance and ISO 9000 in Pharmaceutical Industry. POSYON, 4, 44 (1995)
- Y. Çapan Novel Approaches in Pharmaceutical Dosage Forms Rapor, 8, 4 (1995)
- Y. Çapan Recent Pharmacopeial Controls Used for the Evaluation of Solid Dosage Forms - I. POSYON, 5, 36 (1996)
- F.S. Farshi, Y. Çapan, A.A. Hıncal, Bioavailability File: Furosemide FABAD J. Pharm. Sci., 21, 87 (1996)
- Y. Çapan Recent Pharmacopeial Controls Used for the Evaluation of Solid Dosage Forms - II POSYON, 5, 71 (1996)
- Y.Çapan Controlled-Release Oral Solid Dosage Forms, General Principles Posyon, 5, 117 (1996)
- Y. Yazıksız, Y. Çapan, A.A.Hıncal Buccal Adhesive Drug Delivery Systems FABAD J. Pharm. Sci., 22, 65 (1997)
- H.Selek, Y.Çapan, H.S.Kaş Starch Microspheres: Importance, Preparation and Applications FABAD J. Pharm. Sci., 24, 31 (1999)
- İ. Yenice, S. Çalış, Y. Çapan Quality Control of Conventional and Controlled-Release Carbamazepine Tablets Available in Turkish Market H.U. J. Fac. Pharm., 20, 45 (2000)
R. Elqidra, N. Ünlü, Y.Çapan, A.A. Hıncal Effect of Polymorphism on Carbamazepine Tablet Characteristics H.U. J. Fac. Pharm., 21, 83 (2001)
- S. Bozdağ, İ. Vural, Y. Çapan, T. Dalkara Application of Drug Carrier Systems for Brain Tumor Therapy FABAD J. Pharm. Sci., 27, 89 (2002)
- M.Çetin , Y. Çapan bFGF ( Basic Fibroblast Growth Factor ) and a novel approach to its formulations H.U. J. Fac. Pharm., 24, 107 (2004 )
- M.Cetin,Y.Capan Brain Drug targeting J.Fac.Pharm. Ankara,33,287(2004)
- S. Bozdağ, Y. Çapan, İ. Vural. A.A.Hıncal Method Validation in Determination of Mitoxantrone by HPLC Acta Pharmaceutica Turcica.,46:43 ( 2004) |
|
Book Chapters |
|
- S. Şenel, Y. Çapan and A. A. Hıncal Factors Affecting the Formulation of Sustained Release Potassium Chloride Tablets In: PHARMACEUTICAL TECHNOLOGY Controlled Drug Release Vol. 2 J. I. Wells and Rubinstein (Eds.) pp. 34-43, Ellis Harwood, New York, 1991
- Y. Çapan, Pharmaceutical Factors Affecting Bioavailability and Bioequivalance. In: BIOAVAILABILITY AND BIOEQUIVALANCE L. Öner, M. Şumnu, A.A.Hıncal (Eds.) Şafak Matbaası, Ankara, 1995.
- S. Şenel, Y. Çapan, M.F. Sargon, D. Solpan, O. Güven, H.E. Boddé, A.A. Hıncal, Enhancing Effect of Sodium Glycodeoxycholate on Diffusion Rate of Morphine Sulfate Through Buccal Epithelium In: P. Couvreur, D.D. Duch(ne, I. Kalles, ( Eds), pp. 441- 445, MINUTES, Formulation of Poorly-Available Drugs for Oral Administration, European Symposium, Editions de Santé Publishers, Paris, 1996.
- Y. Çapan Kontrollü Salım Sistemlerinin Salım Mekanizmaları ve Kullanılış Yolları (Release Mechanisms of Controlled Release Systems and Administrations Routes ) In: Kontrollü Salım Sistemleri (Controlled Release Systems)A. Gürsoy (Ed) pp.41-64, Elma Bilgisayar Basım ve Ambalaj San. Tic. Ltd. Şti, İstanbul, 2002.
- Y. Çapan Mukozaya Yapışan Sistemler (Mucoadhesive Systems )In: Kontrollü Salım Sistemleri (Controlled Release Systems) A. Gürsoy (Ed) pp.177-196, Elma Bilgisayar Basım ve Ambalaj San. Tic. Ltd. Şti, İstanbul, 2002.
- Y. Çapan Çözünürlük ve çözünme hızına etki eden faktörler (Solubility and factors effecting solubility rate) In: Farmasötik Teknoloji (Pharmaceutical Technology) A. Gürsoy (Ed.) pp. 85-96, Piksel Bilişim Matbaacılık Reklamcılık ve Filmcilik Hizmetleri Ltd. Şti., İstanbul, 2004.
- Y. Çapan Biyoyararlanım (Bioavailability) In: Farmasötik Teknoloji (Pharmaceutical Technology) A. Gürsoy (Ed.) pp.159-168, Piksel Bilişim Matbaacılık Reklamcılık ve Filmcilik Hizmetleri Ltd. Şti., İstanbul, 2004.
- O. Pinarbasli, Y. Aktas, Y. Capan Development and Validation of an Analytical Method for The Determination of PBN from Chitosan Nanoparticles In: Advances in Chitin Science S.Senel, K.M. Varum, M.M. Sumnu, A.A. Hincal (Eds), pp: 370-375, . Alp Ofset, Ankara, 2007 |
